[Assessment of the hypothalamic-pituitary-adrenal axis in Cushing's disease diagnosis and remission].

Cushing's disease (CD) remains a medical challenge, with many questions still unanswered. Successful treatment of CD patients is closely related to correct approach to syndromic and etiological diagnosis, besides the experience and talent of the neurosurgeon. Pituitary transsphenoidal adenomectomy is the treatment of choice for DC. Assessment of remission after surgery and recurrence in the long term is an even greater challenge. In this regard, special attention should be paid to the role of postoperative serum cortisol as a marker of CD remission. Additionally, the postoperative use of exogenous glucocorticoids only in cases of adrenal insufficiency has been suggested by some authors as an essential practice to enable the use of serum cortisol in this scenario. In this article, we review the forms of evaluation of DC activity, and markers of remission and relapse of CD after transsphenoidal surgery.

[1]  E. Oldfield,et al.  The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  P. Jones,et al.  Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  S. Kunwar,et al.  Utility of the Immediate Postoperative Cortisol Concentrations in Patients With Cushing's Disease , 2010, Neurosurgery.

[4]  P. Chanson,et al.  Metabolic Syndrome in Cushing’s Syndrome , 2010, Neuroendocrinology.

[5]  H. Shahinian,et al.  High Prevalence of Normal Tests Assessing Hypercortisolism in Subjects with Mild and Episodic Cushing's Syndrome Suggests that the Paradigm for Diagnosis and Exclusion of Cushing's Syndrome Requires Multiple Testing , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  W. Selman,et al.  Peri-operative management of Cushing’s disease , 2010, Reviews in Endocrine and Metabolic Disorders.

[7]  N. Martin,et al.  Dexamethasone-suppressed corticotrophin-releasing hormone-stimulation test does not reliably diagnose or predict recurrence of Cushing disease. , 2010, Clinical chemistry.

[8]  G. Arnaldi,et al.  Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  A. Klibanski,et al.  Delayed remission after transsphenoidal surgery in patients with Cushing's disease. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  S. Lamberts,et al.  Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease , 2009, Neuroendocrinology.

[11]  H. Dufour,et al.  A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. , 2009, The Journal of clinical endocrinology and metabolism.

[12]  G. Arnaldi,et al.  Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. , 2009, European journal of endocrinology.

[13]  L. Salgado,et al.  Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease , 2008, Clinical endocrinology.

[14]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  M. Czepielewski,et al.  Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[16]  M. Czepielewski,et al.  Criteria of cure and remission in Cushing's disease: an update. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[17]  J. Acebes,et al.  Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease , 2007, Acta Neurochirurgica.

[18]  M. D. De Martino,et al.  The dexamethasone‐suppressed corticotropin‐releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo‐Cushing's states , 2007, Clinical endocrinology.

[19]  S. Domenice,et al.  Ectopic ACTH syndrome: our experience with 25 cases. , 2006, European journal of endocrinology.

[20]  R. Reznek,et al.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  D. McCance,et al.  Long‐term remission rates after pituitary surgery for Cushing's disease: the need for long‐term surveillance , 2005, Clinical endocrinology.

[22]  E. Laws,et al.  Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  Charles B. Wilson,et al.  Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. , 2004, The Journal of clinical endocrinology and metabolism.

[24]  J. Gross,et al.  Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  J. Romijn,et al.  Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  B. Scheithauer,et al.  Crooke's Cell Adenoma of the Pituitary: An Aggressive Variant of Corticotroph Adenoma , 2003, The American journal of surgical pathology.

[27]  P. Singer,et al.  Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. , 2003, Journal of neurosurgery.

[28]  J. Newell-Price.  Transsphenoidal surgery for Cushing's disease: defining cure and following outcome * , 2002, Clinical endocrinology.

[29]  J. Wass,et al.  Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit * , 2002, Clinical endocrinology.

[30]  C. Lamas,et al.  The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. , 2001, The Journal of clinical endocrinology and metabolism.

[31]  E. Laws,et al.  Serum cortisol response to transsphenoidal surgery for Cushing disease. , 2001, Journal of neurosurgery.

[32]  A. Franzin,et al.  Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease , 2001, Clinical endocrinology.

[33]  P. Kendall‐Taylor,et al.  Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? , 2001, Clinical endocrinology.

[34]  M. Losa,et al.  The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. , 2000, The Journal of clinical endocrinology and metabolism.

[35]  A. Moreira,et al.  Salivary cortisol for screening of Cushing's syndrome in children , 1999, Clinical endocrinology.

[36]  C. Invitti,et al.  Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  D. Papanicolaou,et al.  A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. , 1998, The Journal of clinical endocrinology and metabolism.

[38]  A. Grossman,et al.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. , 1998, Endocrine reviews.

[39]  X. Bertagna,et al.  Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours , 1998, Clinical endocrinology.

[40]  S. Gitelman,et al.  Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[41]  D. Cook,et al.  Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure. , 1997, The Journal of clinical endocrinology and metabolism.

[42]  D. Freedman,et al.  Evidence for the Low Dose Dexamethasone Suppression Test to Screen for Cushing's Syndrome—Recommendations for a Protocol for Biochemistry Laboratories , 1997, Annals of clinical biochemistry.

[43]  M. Boscaro,et al.  Risk factors and long-term outcome in pituitary-dependent Cushing's disease. , 1996, The Journal of clinical endocrinology and metabolism.

[44]  M. Buchfelder,et al.  Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. , 1995, The Journal of clinical endocrinology and metabolism.

[45]  A. Grossman,et al.  A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome , 1995, Clinical endocrinology.

[46]  P. Loi,et al.  Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease. , 1994, European journal of endocrinology.

[47]  D. Lowe,et al.  Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment , 1993, Clinical endocrinology.

[48]  D. Hadden,et al.  Assessment of endocrine function after transsphenoidal surgery for Cushing's disease , 1993, Clinical endocrinology.

[49]  M. Esiri,et al.  TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME? , 1990, Clinical endocrinology.

[50]  X. Bertagna,et al.  Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. , 1988, The Journal of clinical endocrinology and metabolism.

[51]  R. Brooks,et al.  Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. , 1982, The Journal of clinical endocrinology and metabolism.

[52]  F. Esposito,et al.  Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. , 2006, Journal of Clinical Endocrinology and Metabolism.

[53]  F. Esposito,et al.  Early Morning Cortisol Levels as a Predictor of Remission After Transsphenoidal Surgery for Cushing’s Disease , 2006 .

[54]  P. Beck‐Peccoz,et al.  Recurrence of Cushing's Disease Preceded by the Reappearance of ACTH and Cortisol Responses to Desmopressin Test , 2005, Pituitary.

[55]  G. Tindall,et al.  Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. , 1998, The Journal of clinical endocrinology and metabolism.

[56]  Ta‐Jen Wu,et al.  Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[57]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[58]  A. Heaney,et al.  International Journal of General Medicine Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Medical Treatment of Cushing's Disease: Overview and Recent Findings , 2022 .